Our portfolio companies

Nápreva manufactures the first non-addictive, pharmaceutical-quality terpene products for chronic pain relief. Sold as dietary supplements but produced to pharmaceutical manufacturing standards, Ná...

Sinaptica is advancing an Alzheimer's breakthrough with two completely successful randomized sham-controlled Phase 2 trials that met every FDA endpoint, significantly slowing disease progression wi...

MVT Pharma is a late-clinical stage biotech with near-term value inflection points. Its pipeline features a best-in-class microbubble contrast agent for echocardiography that has completed phase II...

Innova NanoJet® Technologies Ltd. a UK/US commercial-stage deep technology company, is redefining air safety with NanoJet®—a patented, filter-less aerosol...

Entos is a genetic medicines company with a technology that enables the development of medicines to treat, and potentially cure, diseases that are currently untreatable Entos represents a rare opportunity to invest in a category-defining platform with the potential to fundamentally reshape the genetic medicine landscape. With demonstrated safety in humans, manufacturing infrastructure, and a strong base of non-dilutive funding, Entos enters this financing from a position of unusual maturity and technical validation. This investment provides exposure to a highly differentiated, platform-scale opportunity with multiple near-term value creation pathways.

Biosartia Microbiomics invites investors to evaluate their lead oral weight-loss asset—a novel GLP-1R positive allosteric modulator (PAM) with selective polypharmacology —and to explore how their d...

Cycling Designs’ product, Cyclesight, provides a real-time view of rear-approaching vehicles, allowing cyclists to react and avoid danger. spend considerable money on safety but there are still too...

Versatope Therapeutics is a clinical-stage biotechnology company developing vaccines and therapeutics using a proprietary nanovesicle platform. Their lead program, VT-105, is a universal flu vaccin...

Animate Biosciences pioneers AI-designed, regenerative biology–inspired peptide drugs for chronic inflammation and fibrosis. They have demonstrated strong in-vivo efficacy in pulmonary, cardiac, an...